E1: complainant street address: (b)(6).Based on the available information, this event is deemed to be a reportable malfunction.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number, reporting site: 1049092, manufacturing site: 1000317571.
|
Additional information - this emdr is being submitted to include the below: h6: investigation results under imdrf cause investigation code, imdrf investigation findings, imdrf cause conclusions h10: investigation summary a batch record review was completed and no discrepancies were found.All in-process stat sample quality checks were satisfactory.Aquacel foam ag adh 21x21(1x5) nai was manufactured under standard operating procedure (sop) code 1703972 and manufacturing lot number 2h00357 on 04 august 2022.Lot # 2h00357 was sterilised under work order (b)(4) and released on review of results of sterilisation provided by sterilisation company steris.All of the results were within specification and products were released.No nonconformity was identified during the manufacturing process of lot 2h00357.This is the only complaint for the affected lot registered within database.Upon receiving the complaint on 06 april 2023, two photographs were received for this issue, confirming the lot and product but were identified as being pixelated and not of good enough image quality to identify the ¿insects¿ that the complainant had reported.The complaint samples and additional photographs were requested on 12th april 2023, but no samples were received from the complainant within 30 days of requesting.2 additional photographs were received via email on 17th april 2023, but still did not have adequate image quality to confirm the complaint issue reporting ¿insects¿.As no samples or adequate images of the reported issue were received, it was not possible to open an nonconformity (nc) or corrective and preventive actions (capa) to investigate this issue fully.The photographs do not show insects, but do appear to show a form of foreign matter.Complaints for foreign matter have been received in the past, with previous nonconformities (ncs) opened to investigate each case by case.Nonconformity (nc) tw (b)(4) was opened most recently for black contamination from the optima manufacturing line, the same line batch 2h00357 was manufactured on.Without the samples and adequate photographs of the complaint samples, it is not possible to complete an investigation for this issue specifically, but as the contamination/foreign matter appears most similar to the black contamination identified from the same line in a different complaint, the nonconformity (nc) already open is considered to cover this complaint issue as well.Further investigation can only take place for this issue with the receipt of the samples, which were requested on 12 april 2023, so have not been received within 30 days.No physical sample has been received.The complaint does have a valid lot number; this complaint will be processed as a type 2 complaint with no physical sample.Should a sample be received for the complaint, the case will be re-opened and investigated under the type 2 evaluation criteria.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092 manufacturing site: 1000317571.
|